| ||||||||
|
Yayınlar Yayınlar 1) Eyol E, Murtaga A, Zhivkova-Galunska M, Georges R, Zepp M, Djandji D, Kleeff J, Few genes are associated with the capability of pancreatic ductal adenocarcinoma
2) Georges R, Bergmann F, Hamdi H, Zepp M, Eyol E, Hielscher T, Berger MR, Adwan H. Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis. J Cell Mol Med. 2012 Feb;16(2):260-72. doi: 10.1111/j.1582-4934.2011.01289.x. PubMed PMID: 21388515.
3) Uhlmann ME, Georges RB, Boleij A, Eyol E, Kubarenko A, Adwan H, Berger MR. Influence of osteopontin expression on the metastatic growth of CC531 rat
colorectal carcinoma cells in rat liver. Cancer Gene Ther. 2011
Nov;18(11):795-805. doi: 10.1038/cgt.2011.48. Epub 2011 Aug 19. PubMed PMID:
21852811.
4) Adwan H, Zhivkova-Galunska M, Georges R, Eyol E, Kleeff J, Giese NA, Friess H, Bergmann F, Berger MR. Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma. Br J Cancer. 2011
Jul 12;105(2):288-95. doi: 10.1038/bjc.2011.217. Epub 2011 Jun 28. PubMed PMID:
21712827; PubMed Central PMCID: PMC3142801.
5) Georges R, Adwan H, Zhivkova M, Eyol E, Bergmann F, Berger MR. Regulation of osteopontin and related proteins in rat CC531 colorectal
cancer cells. Int J Oncol. 2010 Aug;37(2):249-56.
6) Zhivkova-Galunska M, Adwan H, Eyol E, Kleeff J, Kolb A, Bergmann F, Berger MR. Osteopontin but not osteonectin favors the metastatic growth of
pancreatic cancer cell lines. Cancer Biol Ther. 2010 Jul;10(1):54-64.
Epub 2010 Jul 26.
7) Eyol E, Boleij A, Taylor RR, Lewis AL, Berger MR. Chemoembolisation of rat colorectal liver metastases with drug
eluting beads loaded with irinotecan or doxorubicin. Clin. Exp.
Metastasis. 2008;25(3):273-82.
8) Voss C, Eyol E, Frank M, von der Lieth CW, Berger MR. Identification and characterization of riproximin, a new type II
ribosome-inactivating protein with antineoplastic activity from Ximenia
americana. FASEB J. 2006 Jun;20(8):1194-6
9) Voss C, Eyol E, Berger MR Identification of potent anticancer activity in Ximenia americana
aqueous extracts used by African traditional medicine. Toxicol Appl
Pharmacol. 2006 Mar 15;211(3):177-87.
10) Rodenbach M, Eyol E, Seelig MH, Berger MR. Combination treatment of CC531-lac-Z rat liver metastases by
chemoembolization with pemetrexed disodium and gemcitabine. J
Cancer Res Clin Oncol. 2005 May;131(5):289-99.
11) Hasbahceci M, Kiyan M, Eyol E, Ewalt LC, Lodmell DL. Human diploid-cell rabies vaccine: efficacy of four doses.
Lancet. 1996 Apr 6;347(9006):976-7
Abstract 1) Eyol E.1, Adwan H.1, Zhivkova M.1, Zepp M.1, Djandji D.2, Kleeff J.3, Development of rat models for pancreatic cancer liver metastasis.
1DKFZ, G401, Heidelberg; 2DKFZ, D050, Heidelberg; 3Technical
University Munich, Department of Surgery, München
28. Deutscher Krebskongress 20-23. Februar 2008 Berlin
2) Georges R., Adwan H., Zhivkova M., Eyol E., Berger M. Comparative gene expression of CC531 rat colorectal cancer cells in rat
liver versus hepatocyte-based co-culture models. DKFZ, G401,
Heidelberg 28. Deutscher Krebskongress 20-23. Februar 2008 Berlin
3) M. Zhivkova, E. Eyol, D. Stolarcyk, M.R. Berger ERK and P38 status of pancreatic cancer cell lines predict for tumor
dormancy in vivo. DKFZ, G401, Heidelberg Internationaler AEK Krebskongress –
28. Februar bis 2. März
4) Uhlmann M., Boleij A., Eyol E., Berger M. Treatment of rat colorectal liver metastasis with an antisense
oligonucleotide against osteopontin. DKFZ, G401, Heidelberg
Internationaler AEK Krebskongress - 28. Februar bis 2. März
Frankfurt am Main
5) Ergyl Eyol, Hassan Adwan, Martin R. Berger Interaction of the transcription factor osf2 with the progression markers osteopontin, bone
sialoprotein and osteonectin in vitro. (DKFZ, Heidelberg) 13th
International AEK/AIO Congress of the German Cancer Society.
Wurzburg, Germany, March 13-16, 2005. 6) Cristina Voss, Ergül Eyol, Martin R. Berger Plant material used in African traditional medicine shows antineoplastic activity in vitro and in
vivo. (DKFZ, Heidelberg) 13th International AEK/AIO Congress of the
German Cancer Society. Wurzburg, Germany, March 13-16, 2005.
7) Michael Rodenbach, Ergyl Eyol and Martin R. Berger Combination with gemcitabine renders dose dependent anti-cancer
activity on alimta in rats with colorectal liver metastasis. (DKFZ,
Heidelberg) American Association for Cancer Research • 95th Annual
Meeting March 27-31, 2004 Orlando, FL
| |||||||
İnönü Üniversitesi Merkez Kampüsü, 44280, Malatya, Türkiye, Tel: +90 422 377 30 00 | ||||||||